Cargando…

Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis

Clinical management of prostate cancer is challenging because of its highly variable natural history and so there is a need for improved predictors of outcome in non-metastatic men at the time of diagnosis. In this study we calculated the model score from the leading clinical multivariable model, PR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wardale, Lewis, Cardenas, Ryan, Gnanapragasam, Vincent J., Cooper, Colin S., Clark, Jeremy, Brewer, Daniel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857957/ https://www.ncbi.nlm.nih.gov/pubmed/36661662 http://dx.doi.org/10.3390/curroncol30010013

Ejemplares similares

Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model
por: Thurtle, David R., et al.
Publicado: (2019)

Integration of Urinary EN2 Protein & Cell-Free RNA Data in the Development of a Multivariable Risk Model for the Detection of Prostate Cancer Prior to Biopsy
por: Connell, Shea P., et al.
Publicado: (2021)

Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)
por: Thurtle, David, et al.
Publicado: (2020)

Development of a multivariable risk model integrating urinary cell DNA methylation and cell‐free RNA data for the detection of significant prostate cancer
por: Connell, Shea P., et al.
Publicado: (2020)

A novel stratification framework for predicting outcome in patients with prostate cancer
por: Luca, Bogdan-Alexandru, et al.
Publicado: (2020)

The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers
por: Ball, Richard Y., et al.
Publicado: (2021)

Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns
por: Guo, Xiangqian, et al.
Publicado: (2018)

Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors
por: Barrett, Tristan, et al.
Publicado: (2015)

Novel concepts for risk stratification in prostate cancer
por: Patel, Keval M, et al.
Publicado: (2016)

Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
por: Schoots, Ivo G., et al.
Publicado: (2019)

Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study
por: Gnanapragasam, Vincent J., et al.
Publicado: (2016)

Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance
por: Light, Alexander, et al.
Publicado: (2022)

Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer
por: Yazbek Hanna, Marcelino, et al.
Publicado: (2023)

Refining developmental coordination disorder subtyping with multivariate statistical methods
por: Lalanne, Christophe, et al.
Publicado: (2012)

Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype
por: Han, Hyunho, et al.
Publicado: (2021)

Convergence of Prognostic Gene Signatures Suggests Underlying Mechanisms of Human Prostate Cancer Progression
por: Luca, Bogdan-Alexandru, et al.
Publicado: (2020)

Composite risk stratification models optimise the value of imaging in prostate cancer staging
por: McAllister, Tom, et al.
Publicado: (2023)

Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer.
por: de Mello, J., et al.
Publicado: (1983)

Urinary symptoms and prostate cancer—the misconception that may be preventing earlier presentation and better survival outcomes
por: Gnanapragasam, Vincent J., et al.
Publicado: (2022)

A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data
por: O’Connell, Shea P., et al.
Publicado: (2022)

Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer
por: Seltzer, Sean, et al.
Publicado: (2022)

Renal Function Parameters in Distinctive Molecular Subtypes of Prostate Cancer
por: Timofte, Andrei Daniel, et al.
Publicado: (2023)

Understanding of prognosis in non-metastatic prostate cancer: a randomised comparative study of clinician estimates measured against the PREDICT prostate prognostic model
por: Thurtle, David R., et al.
Publicado: (2019)

The molecular basis for ethnic variation and histological subtype differences in prostate cancer
por: ZONG, Yang, et al.
Publicado: (2013)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2021)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Characterization of Immune-Based Molecular Subtypes and Prognostic Model in Prostate Adenocarcinoma
por: Guo, Li, et al.
Publicado: (2022)

Identification of senescence-related molecular subtypes and key genes for prostate cancer
por: Feng, De-Chao, et al.
Publicado: (2022)

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
por: Leivonen, S-K, et al.
Publicado: (2017)

Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures
por: Wadhwa, Karan, et al.
Publicado: (2017)

Multi-transcript profiling in archival diagnostic prostate cancer needle biopsies to evaluate biomarkers in non-surgically treated men
por: Kachroo, Naveen, et al.
Publicado: (2014)

Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom
por: Philippou, Yiannis, et al.
Publicado: (2015)

Prospective Implementation and Early Outcomes of a Risk-stratified Prostate Cancer Active Surveillance Follow-up Protocol
por: Thankapannair, Vineetha, et al.
Publicado: (2023)

Prostatic carcinoma: a multivariate analysis of prognostic factors.
por: Berner, A., et al.
Publicado: (1994)

Evaluation of transabdominal and transperineal ultrasound-derived prostate specific antigen (PSA) density and clinical utility compared to MRI prostate volumes: A feasibility study
por: Pantelidou, Maria, et al.
Publicado: (2022)

Role and expression of FRS2 and FRS3 in prostate cancer
por: Valencia, Tania, et al.
Publicado: (2011)

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
por: Wang, Qi, et al.
Publicado: (2017)

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
por: Liu, Deli, et al.
Publicado: (2020)

A Feasibility Study of the Therapeutic Response and Durability of Short-term Androgen-targeted Therapy in Early Prostate Cancer Managed with Surveillance: The Therapeutics in Active Prostate Surveillance (TAPS01) Study
por: Barrett, Tristan, et al.
Publicado: (2022)

A MATLAB companion for multivariable calculus
por: Cooper, Jeffery
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_8jb16urravqoo3klsnauie77b9